Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Low Intensity- Extracorporeal Shockwave Therapy in Drug Resistant Hypertension

NCT02042066 is registered in ClinicalTrials.gov with Medispec as lead sponsor.

NCT NCT02042066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Low Intensity- Extracorporeal Shockwave Therapy in Drug Resistant Hypertension
Lead sponsor
Medispec
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2015
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, resistant to conventional therapy